An international case-control study of primary pediatric brain tumors Spain and 86 to 92% at the three U.S. centers. The composition of the various multivitamin compounds taken also varied: the daily dose of vitamin C ranged from 0 to 600 mg, vitamin E ranged from 0 to 70 mg, vitamin A ranged from 0 to 30,000 IU, and folate ranged from 0 to 2000 pg. Mothers also took individual micronutrient supplements (e.g., vitamin C tablets), but most mothers who took these also took multivitamins, making it impossible to determine potential independent effects of these micronutrients.
Introduction
Brain tumors are a leading cause of cancer deaths in children in developed countries (1) . Little is known about the causes of these tumors (2) . A family history of multiple nervous system tumors, which usually occur in association with predisposing genetic syndromes, appears to be a factor in fewer than 5% of cases (3) . Exposure to X-rays and to other forms of ionizing radiation is the only clearly established environmental cause but accounts for only a few percent of cases (4) . Many other suggested risk factors have been investigated including head trauma, parental occupational exposures, medication use, and diet (4) . This paper looks at maternal use of prenatal vitamin supplements.
An incidental finding in an early case-control study of pediatric brain tumors provided the first indication that prenatal vitamin supplementation might be related to reduced brain tumor risk (5) . In this study, mothers were asked about the use of several specific medications during pregnancy; in answer to a final question about any other drugs, more control mothers than case mothers volunteered that they had taken prenatal vitamins (odds ratio [OR] 0.6) (5). More than a decade later, several studies reported similarly decreased risk related to maternal use of prenatal vitamins. These include studies of specific histologic subgroups of cases such as primitive neuroectodermal tumors (PNET) (6) and astrocytoma (2) and studies of all types of pediatric brain tumors combined (7) . In the largest study to date, decreased risk related to prenatal vitamin supplementation was apparent for all types of tumors combined as well as for each of the three major subtypes (astroglial tumors, PNET, and other glial tumors) (8) . This paper includes data from the Preston-Martin et al. (8) study, which was the U.S. portion of an international collaborative study of childhood brain tumors, as well as data from centers in France, Italy, Spain, Israel, and Canada.
Methods
We investigated whether intake of vitamin supplements by the mother during pregnancy, during the month before pregnancy, or while breast feeding were related to risk of pediatric brain tumors, including each of three major histologic subgroups of these tumors. Dose Valencia, Milan, and Israel) also used geographic region as a matching variable. Unconditional risk estimates for Seattle and Winnipeg were also adjusted for geographic region. For the other centers that matched on region (Valencia, Milan, and Israel), there were too many regional levels to allow for adjustment in unconditional analyses. For individually matched studies, strata for conditional analyses were defined by matched sets; for frequency matched studies, strata were defined by center, sex, and age group (0-1, 2-3, 4-5, 6-8, 9-11, 12-14, or 15-19 years of age). Because estimates were similar using both conditional and unconditional methods, only results from unconditional analyses are reported. Birth year, parents' education, and child's use of vitamin supplements were considered potential confounders. Parents' education was defined as the highest level attained by either parent and was dichotomized for analysis; parents in the upper level had at least some college education. Race was not considered a confounder because of its homogeneity within each center except Los Angeles (race as a potential confounder in the U.S. data is addressed in "Discussion"). Risk estimates and CIs from random effects models (with center as the random effect) are reported for exposure effects that differed by center (14) ; otherwise, results from fixed effects models are reported. Other factors considered as possible effect modifiers were gender, birth year, and parents' education. For tumor-specific analyses, cases within each tumor group were compared to all controls. Morphologic subgroups were defined by the World Health Organization (8) 
Discussion
Intake of vitamin supplements during pregnancy was associated with an apparent reduction of risk in earlier studies (2, (5) (6) (7) 9) and in this largest case-control study of childhood brain tumors to date. Risk reduction appeared to relate only to use during pregnancy rather than use during the month before pregnancy or during breast feeding, and the greatest risk reduction was observed when vitamins were taken during the entire pregnancy. The reduction of risk was greatest among children diagnosed at younger ages (< 5 years at diagnosis), but also was seen among older children.
This international study has a number of limitations that must be considered. The small number of cases in most centers (< 100 cases in all but the U.S. and Israeli studies) and the low prevalence of vitamin use in some geographic areas (e.g., 3% among control mothers in Israel and Paris) resulted in varied center-specific risk estimates and combined risk estimates that were dominated by findings in the United States, where vitamins were taken by the majority of mothers. In fact, the non-U.S. data added only a 14% increase in number of exposed cases and a 19% increase in number of exposed controls, despite increases of 126 Table 6 .
There is a suggestion that an increasing reduction in risk occurs with increasing daily intake of each micronutrient evaluated (vitamins C, E, A, and folate), but because most mothers took a multivitamin compound, intake of these four was highly correlated. In addition, specific brand names of vitamins taken were not known or not recorded for many mothers (though U.S. centers asked about specific types of multivitamins taken). As in any retrospective case-control study, the possible influence of recall bias is a concern. We did not have the necessary data to perform a validation analysis against medical records. However, in studies of childhood cancer, recall bias is usually associated with case mothers trying harder than control mothers to remember medication use and other exposures during the index pregnancy. If such bias is present in relation to an apparently protective exposure such as vitamin use, it would have had the effect of biasing our risk estimates toward the null. Further, there is some evidence to suggest that recall bias does not exist in studies of adverse reproductive outcomes that use mothers as respondents (15) . Though the lower risk estimates we observed for later birth years may be due to increasing prevalence of supplementation over time, they may also suggest nondifferential poor recall among mothers whose pregnancies were in the distant past.
In the U.S. portion of the study, findings relating to vitamin use remained after controlling for all factors considered in the pooled analysis, as well as the mother's education, social class (an index considering education and occupation of head of household), ethnicity (Latino, other white, black, and other), and the mother's diet during pregnancy (9) . The U.S. data were also evaluated with respect to whether pregnancies were planned, which did not confound the U.S. results. It is possible that respondents differed from nonrespondents in these factors or in the exposures we studied (although participation rates at the U.S. centers were 70% or higher), or that controls targeted for participation (through random-digit dialing) were not representative of the population. However, these potential biases are not quantifiable in this study. We are processing the dietary data from each center to allow a combined analysis of micronutrient intake from diet and supplements, which will be particularly useful for centers in which prevalence of supplementation was low (e.g., Israel and France) and thus a minor contributor to population intake of micronutrients.
The dietary analysis will also allow us to examine the modifying effects of supplement intake in relationship to other dietary constituents such as nitrite from cured meats (an important consideration because both vitamins C and E are effective inhibitors of nitrosation, as described below). However, the dietary data from this study have their own set of limitations. The focus of this study was investigation of the Nnitroso hypothesis. Therefore, the questionnaire asked only about those 40 to 50 foods that account for 90% of population intake of nitrite, nitrate, and vitamins C and E in each geographic area under study (16) . The list of foods queried varied considerably across centers. In addition, these lists were not designed to assess intake of most micronutrients (e.g., folate and vitamin A) or macronutrients (e.g., fat or animal protein). The Israel study is an exception, however, in that relatively complete dietary data (i.e., not just foods most correlated with intake of nitrite, nitrate, and vitamins C and E) were collected.
Our data suggest an increasing use of prenatal vitamin supplements over time, which is inconsistent with the modest increase in U.S. incidence of pediatric brain tumors over the past 20 years (17). However, increased incidence is likely due to the simultaneous effects of several different factors, such as improved diagnosis and possible secular changes in environmental exposures that may increase risk. The effects of these potential influences on pediatric brain tumor incidence cannot be disentangled when comparing the trends in incidence and prevalence of this single exposure.
Nitrite from cured meats is an important precursor of carcinogenic N-nitroso compounds commonly formed in the gut after ingestion of precursor compounds (18, 19) . One group of these compounds, the nitrosoureas, causes nervous system tumors in experimental animals (20) (21) (22) (23) (24) . When exposure is transplacental, only low doses of precursors such as sodium nitrite and ethyl urea in the food and drinking water of the pregnant rats are required for 100% tumor induction in offspring. This effect can be blocked if ascorbate (vitamin C) and/or alpha-tocopherol (vitamin E) are added to the dams' diet (25) . In the U.S. portion of this study, we found risk of brain tumors to be substantially higher for children of mothers who consumed above-average quantities of cured meats during their pregnancies and did not take vitamins compared with those who did (9) . This synergism also was seen in a small earlier study (7) . The (26) . Antioxidants (e.g., vitamins C and E) can prevent oxidative damaige to DNA by scavenging free radicals (27) . Some micronutrients such as vitamins A and D have a role in cell differentiation and proliferation (28) . Supplementation may prevent deficiencies, such as folic acid deficiency, that may lead to malignant transformation of normal cells by weakening chromosomal structure and altering gene expression (29) . Presence of micronutrients in the gut or bladder can prevent endogenous formation of carcinogens (such as N-nitroso compounds) or alter metabolism of mutagens. It is possible that the developing brain may be more susceptible to some of these effects because of the higher rate of brain cell proliferation during gestation and early childhood and the fetal brain's lower ability to rid itself of mutagenic compounds (30) .
Our findings of a huge variation in prevalence of prenatal vitamin use and of the content of vitamin compounds across countries may be of interest to clinicians and public health workers. In addition, we hope that our findings will stimulate investigators to consider vitamin supplementation in future epidemiologic studies of childhood brain tumors and other pediatric cancers.
